Compare
Zone Frontier Inc. vs Longevity Health Holdings, Inc. vs Park Ha Biological Technology Co., Ltd. vs DSwiss Inc
| Latest fiscal year | Zone Frontier Inc. ZONE | Longevity Health Holdings, Inc. XAGE | Park Ha Biological Technology Co., Ltd. BYAH | DSwiss Inc DQWS |
|---|---|---|---|---|
| Year ended | 2025-06-30 | 2025-12-31 | 2025-10-31 | 2025-12-31 |
| Revenue | $2.07M | $1.91M | $2.52M | $2.92M |
| Revenue growth (YoY) | +29.2% | n/m | +6.0% | -6.2% |
| Gross margin | 47.6% | 57.2% | 94.4% | 19.3% |
| Operating margin | -308.1% | -371.6% | -956.5% | 0.0% |
| Net margin | -325.3% | -361.0% | -965.0% | -2.6% |
| Net income | -$6.74M | -$6.91M | -$24.36M | -$76.9K |
| EPS (Diluted) | n/a | -$4.83 | -$41.38 | $0.00 |
| Operating cash flow | -$2.34M | -$3.33M | $85.9K | -$94.3K |
| Free cash flow | -$2.37M | -$3.34M | -$3.0K | -$135.3K |
| Cash & equivalents | $1.46M | $706.7K | $3.79M | $285.0K |
| Total assets | $8.47M | $2.37M | $5.95M | $677.1K |
| Total liabilities | $7.00M | $8.23M | $1.96M | $686.5K |
| Shareholders' equity | $1.47M | -$5.87M | $3.99M | -$9.3K |
| Return on year-end equity | -459.9% | n/a | -609.9% | n/a |
| Shares outstanding | n/a | 1.78M | n/a | 206.90M |
Revenue, most recent five fiscal years
| Fiscal year | Zone Frontier Inc. | Longevity Health Holdings, Inc. | Park Ha Biological Technology Co., Ltd. | DSwiss Inc |
|---|---|---|---|---|
| Latest | $2.07M Ended 2025-06-30 | $1.91M Ended 2025-12-31 | $2.52M Ended 2025-10-31 | $2.92M Ended 2025-12-31 |
| 1 year earlier | $1.60M Ended 2024-06-30 | $50.3K Ended 2024-12-31 | $2.38M Ended 2024-10-31 | $3.11M Ended 2024-12-31 |
| 2 years earlier | n/a | $0 Ended 2023-12-31 | $2.46M Ended 2023-10-31 | $1.47M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $1.92M Ended 2022-10-31 | $1.85M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | n/a | $1.96M Ended 2021-12-31 |